Factors influencing time to diagnosis and treatment among pediatric oncology patients in Kenya.
F Njuguna, H Martijn, S Langat...
https://pubmed.ncbi.nlm.nih.gov/27184775/Actively Recruiting
Led by Resonance, Inc. · Updated on 2026-09-29
6000
Participants Needed
6
Research Sites
N/A
Total Duration
Cancer is a major cause of illness and death among children, adolescents, and young adults CAYAs, particularly in low- and middle-income countries LMICs where access to timely diagnosis and treatment is often limited. This prospective, multicenter observational study follows CAYAs with cancer receiving routine care at participating hospitals in LMICs, aiming to better understand treatment outcomes and challenges faced by patients and families. Participants receive standard medical care as provided by their local hospitals without experimental treatments or changes to their treatment plans. The study observes a single group of patients over time to collect information from medical records and questionnaires focusing on access to care and social factors impacting treatment. The study covers a follow-up period extending up to 36 months after enrollment. During the study, researchers will gather data on clinical outcomes, treatment complications, interruptions, and social factors affecting care. Data collection includes medical record reviews and patient or family questionnaires. The study aims to provide valuable information to help improve cancer care and outcomes in resource-limited settings, with total participant engagement lasting up to three years.
CONDITIONS
CAYA Cancer Prospective Cohort Study
G
Gabriela Villanueva, MD.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Resonance, Inc.
Lead Sponsor
Servier Affaires Médicales
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 36 months
Participants receive their routine cancer care at local hospitals. Researchers collect data from medical records and ask questionnaires about social factors and access to care.
Regular visits as part of routine care
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
F Njuguna, H Martijn, S Langat...
https://pubmed.ncbi.nlm.nih.gov/27184775/B J Brown, S O Ajayi, O A Ogun...
https://pubmed.ncbi.nlm.nih.gov/21503176/Wangzhong Li, Hengrui Liang, Wei Wang...
https://pubmed.ncbi.nlm.nih.gov/39434099/Freddie Bray, Mathieu Laversanne, Elisabete Weiderpass...
https://pubmed.ncbi.nlm.nih.gov/34086348/Bella S Ehrlich, Michael J McNeil, Linh T D Pham...
https://pubmed.ncbi.nlm.nih.gov/37517410/Justyna Derebas, Kinga Panuciak, Mikołaj Margas...
https://pubmed.ncbi.nlm.nih.gov/35326719/Alexandre Chan, Lawson Eng, Changchuan Jiang...
https://pubmed.ncbi.nlm.nih.gov/39268694/Carlos Rodriguez-Galindo, Paola Friedrich, Patricia Alcasabas...
https://pubmed.ncbi.nlm.nih.gov/26304881/William C Temple, Stephanie Mueller, Michelle L Hermiston...
https://pubmed.ncbi.nlm.nih.gov/36907639/Anita Nath, Prashant Mathur, K L Sudarshan...
https://pubmed.ncbi.nlm.nih.gov/37694177/Resonance, Inc.
Lead Sponsor
Servier Affaires Médicales
Collaborating Sponsor